nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine triphosphate—ABCB11—Vincristine—sarcoma	0.0964	0.255	CbGbCtD
Adenosine triphosphate—ABCB11—Doxorubicin—sarcoma	0.0602	0.159	CbGbCtD
Adenosine triphosphate—ABCC2—Vincristine—sarcoma	0.0507	0.134	CbGbCtD
Adenosine triphosphate—ABCC2—Etoposide—sarcoma	0.0464	0.123	CbGbCtD
Adenosine triphosphate—ABCC2—Doxorubicin—sarcoma	0.0317	0.0837	CbGbCtD
Adenosine triphosphate—ABCB1—Dactinomycin—sarcoma	0.0268	0.0709	CbGbCtD
Adenosine triphosphate—ABCB1—Mitoxantrone—sarcoma	0.024	0.0635	CbGbCtD
Adenosine triphosphate—ABCB1—Vincristine—sarcoma	0.0165	0.0437	CbGbCtD
Adenosine triphosphate—ABCB1—Etoposide—sarcoma	0.0151	0.04	CbGbCtD
Adenosine triphosphate—ABCB1—Doxorubicin—sarcoma	0.0103	0.0273	CbGbCtD
Adenosine triphosphate—Adenosine monophosphate—CREB1—sarcoma	0.00478	0.712	CrCbGaD
Adenosine triphosphate—Adenosine monophosphate—SRC—sarcoma	0.00193	0.288	CrCbGaD
Adenosine triphosphate—HSPA1A—Vindesine—Vincristine—sarcoma	0.00176	0.21	CbGdCrCtD
Adenosine triphosphate—ACVRL1—uterus—sarcoma	0.00118	0.0041	CbGeAlD
Adenosine triphosphate—ALK—hematopoietic system—sarcoma	0.00117	0.00407	CbGeAlD
Adenosine triphosphate—NT5C2—myometrium—sarcoma	0.00116	0.00403	CbGeAlD
Adenosine triphosphate—ACVR1—myometrium—sarcoma	0.00116	0.00403	CbGeAlD
Adenosine triphosphate—ADRBK1—embryo—sarcoma	0.00114	0.00396	CbGeAlD
Adenosine triphosphate—ADRBK2—tendon—sarcoma	0.00114	0.00396	CbGeAlD
Adenosine triphosphate—ACSS2—myometrium—sarcoma	0.00114	0.00395	CbGeAlD
Adenosine triphosphate—ACSL1—myometrium—sarcoma	0.00113	0.00392	CbGeAlD
Adenosine triphosphate—ALK—connective tissue—sarcoma	0.00113	0.00392	CbGeAlD
Adenosine triphosphate—ASNA1—smooth muscle tissue—sarcoma	0.00113	0.00392	CbGeAlD
Adenosine triphosphate—ASNA1—skin of body—sarcoma	0.00111	0.00387	CbGeAlD
Adenosine triphosphate—HSPA1A—Podofilox—Etoposide—sarcoma	0.00111	0.132	CbGdCrCtD
Adenosine triphosphate—HSPA1A—cardiac atrium—sarcoma	0.00111	0.00385	CbGeAlD
Adenosine triphosphate—HSPA1B—cardiac atrium—sarcoma	0.00111	0.00385	CbGeAlD
Adenosine triphosphate—ADRBK2—bone marrow—sarcoma	0.00111	0.00384	CbGeAlD
Adenosine triphosphate—HSPA1A—uterus—sarcoma	0.0011	0.00383	CbGeAlD
Adenosine triphosphate—HSPA1B—uterus—sarcoma	0.0011	0.00383	CbGeAlD
Adenosine triphosphate—AFG3L2—skin of body—sarcoma	0.0011	0.00382	CbGeAlD
Adenosine triphosphate—NAE1—smooth muscle tissue—sarcoma	0.00109	0.00377	CbGeAlD
Adenosine triphosphate—NAE1—skin of body—sarcoma	0.00107	0.00372	CbGeAlD
Adenosine triphosphate—ACSS1—seminal vesicle—sarcoma	0.00107	0.00372	CbGeAlD
Adenosine triphosphate—ACVR1—seminal vesicle—sarcoma	0.00105	0.00364	CbGeAlD
Adenosine triphosphate—NT5C2—seminal vesicle—sarcoma	0.00105	0.00364	CbGeAlD
Adenosine triphosphate—ADK—mammary gland—sarcoma	0.00105	0.00364	CbGeAlD
Adenosine triphosphate—ARAF—cardiac atrium—sarcoma	0.00104	0.0036	CbGeAlD
Adenosine triphosphate—ACVRL1—tendon—sarcoma	0.00104	0.00359	CbGeAlD
Adenosine triphosphate—ABCG1—tendon—sarcoma	0.00104	0.00359	CbGeAlD
Adenosine triphosphate—ARAF—uterus—sarcoma	0.00103	0.00358	CbGeAlD
Adenosine triphosphate—ACSS2—seminal vesicle—sarcoma	0.00103	0.00357	CbGeAlD
Adenosine triphosphate—ACSL1—seminal vesicle—sarcoma	0.00102	0.00355	CbGeAlD
Adenosine triphosphate—ADRBK1—hematopoietic system—sarcoma	0.00102	0.00354	CbGeAlD
Adenosine triphosphate—AMHR2—lymph node—sarcoma	0.00101	0.0035	CbGeAlD
Adenosine triphosphate—ABCA1—hematopoietic system—sarcoma	0.00101	0.0035	CbGeAlD
Adenosine triphosphate—NT5C2—hematopoietic system—sarcoma	0.000997	0.00346	CbGeAlD
Adenosine triphosphate—ACSS2—hematopoietic system—sarcoma	0.000977	0.00339	CbGeAlD
Adenosine triphosphate—AKT1—myometrium—sarcoma	0.000976	0.00339	CbGeAlD
Adenosine triphosphate—ASNS—myometrium—sarcoma	0.000976	0.00339	CbGeAlD
Adenosine triphosphate—APAF1—lymph node—sarcoma	0.000975	0.00338	CbGeAlD
Adenosine triphosphate—ASNA1—cardiac atrium—sarcoma	0.000973	0.00338	CbGeAlD
Adenosine triphosphate—ABCC8—mammary gland—sarcoma	0.000972	0.00337	CbGeAlD
Adenosine triphosphate—ACSL1—hematopoietic system—sarcoma	0.000971	0.00337	CbGeAlD
Adenosine triphosphate—ABCA1—connective tissue—sarcoma	0.000971	0.00337	CbGeAlD
Adenosine triphosphate—ASNA1—uterus—sarcoma	0.000967	0.00336	CbGeAlD
Adenosine triphosphate—HSPA1A—tendon—sarcoma	0.000966	0.00335	CbGeAlD
Adenosine triphosphate—HSPA1B—tendon—sarcoma	0.000966	0.00335	CbGeAlD
Adenosine triphosphate—ARAF—lymphoid tissue—sarcoma	0.000961	0.00334	CbGeAlD
Adenosine triphosphate—ACVR1—connective tissue—sarcoma	0.00096	0.00333	CbGeAlD
Adenosine triphosphate—AFG3L2—cardiac atrium—sarcoma	0.00096	0.00333	CbGeAlD
Adenosine triphosphate—AFG3L2—uterus—sarcoma	0.000955	0.00332	CbGeAlD
Adenosine triphosphate—ADRBK2—testis—sarcoma	0.000945	0.00328	CbGeAlD
Adenosine triphosphate—ACSS2—connective tissue—sarcoma	0.000941	0.00327	CbGeAlD
Adenosine triphosphate—AKT1—embryo—sarcoma	0.000939	0.00326	CbGeAlD
Adenosine triphosphate—NAE1—cardiac atrium—sarcoma	0.000937	0.00325	CbGeAlD
Adenosine triphosphate—HSPA1B—bone marrow—sarcoma	0.000936	0.00325	CbGeAlD
Adenosine triphosphate—HSPA1A—bone marrow—sarcoma	0.000936	0.00325	CbGeAlD
Adenosine triphosphate—ACSL1—connective tissue—sarcoma	0.000935	0.00324	CbGeAlD
Adenosine triphosphate—NAE1—uterus—sarcoma	0.000932	0.00323	CbGeAlD
Adenosine triphosphate—PRKAA1—hematopoietic system—sarcoma	0.000919	0.00319	CbGeAlD
Adenosine triphosphate—ARAF—tendon—sarcoma	0.000904	0.00314	CbGeAlD
Adenosine triphosphate—ADRBK1—smooth muscle tissue—sarcoma	0.000898	0.00312	CbGeAlD
Adenosine triphosphate—ADRBK2—liver—sarcoma	0.000893	0.0031	CbGeAlD
Adenosine triphosphate—AFG3L2—lymphoid tissue—sarcoma	0.00089	0.00309	CbGeAlD
Adenosine triphosphate—PRKAA1—connective tissue—sarcoma	0.000885	0.00307	CbGeAlD
Adenosine triphosphate—ASNS—seminal vesicle—sarcoma	0.000882	0.00306	CbGeAlD
Adenosine triphosphate—AKT1—seminal vesicle—sarcoma	0.000882	0.00306	CbGeAlD
Adenosine triphosphate—NT5C2—smooth muscle tissue—sarcoma	0.000878	0.00305	CbGeAlD
Adenosine triphosphate—ABCA1—skin of body—sarcoma	0.000876	0.00304	CbGeAlD
Adenosine triphosphate—ARAF—bone marrow—sarcoma	0.000875	0.00304	CbGeAlD
Adenosine triphosphate—SLC25A4—cardiac atrium—sarcoma	0.000873	0.00303	CbGeAlD
Adenosine triphosphate—NAE1—lymphoid tissue—sarcoma	0.000869	0.00301	CbGeAlD
Adenosine triphosphate—ABCG1—testis—sarcoma	0.000857	0.00298	CbGeAlD
Adenosine triphosphate—ACVRL1—testis—sarcoma	0.000857	0.00298	CbGeAlD
Adenosine triphosphate—TNK2—uterus—sarcoma	0.000851	0.00295	CbGeAlD
Adenosine triphosphate—ASS1—myometrium—sarcoma	0.000851	0.00295	CbGeAlD
Adenosine triphosphate—ACSS2—skin of body—sarcoma	0.00085	0.00295	CbGeAlD
Adenosine triphosphate—ASNA1—tendon—sarcoma	0.000848	0.00294	CbGeAlD
Adenosine triphosphate—AKT1—hematopoietic system—sarcoma	0.000838	0.00291	CbGeAlD
Adenosine triphosphate—AFG3L2—tendon—sarcoma	0.000837	0.0029	CbGeAlD
Adenosine triphosphate—ADCY1—testis—sarcoma	0.000831	0.00288	CbGeAlD
Adenosine triphosphate—ALK—lymphoid tissue—sarcoma	0.000826	0.00287	CbGeAlD
Adenosine triphosphate—ASNA1—bone marrow—sarcoma	0.000821	0.00285	CbGeAlD
Adenosine triphosphate—NAE1—tendon—sarcoma	0.000816	0.00283	CbGeAlD
Adenosine triphosphate—ABCC9—testis—sarcoma	0.000815	0.00283	CbGeAlD
Adenosine triphosphate—AFG3L2—bone marrow—sarcoma	0.000811	0.00281	CbGeAlD
Adenosine triphosphate—ABCG1—liver—sarcoma	0.00081	0.00281	CbGeAlD
Adenosine triphosphate—ACVRL1—liver—sarcoma	0.00081	0.00281	CbGeAlD
Adenosine triphosphate—AKT1—connective tissue—sarcoma	0.000807	0.0028	CbGeAlD
Adenosine triphosphate—HSPA1B—testis—sarcoma	0.0008	0.00278	CbGeAlD
Adenosine triphosphate—HSPA1A—testis—sarcoma	0.0008	0.00278	CbGeAlD
Adenosine triphosphate—NAE1—bone marrow—sarcoma	0.000791	0.00275	CbGeAlD
Adenosine triphosphate—ADCY1—liver—sarcoma	0.000786	0.00273	CbGeAlD
Adenosine triphosphate—ACSS1—cardiac atrium—sarcoma	0.000774	0.00269	CbGeAlD
Adenosine triphosphate—ABCC9—liver—sarcoma	0.00077	0.00267	CbGeAlD
Adenosine triphosphate—ASS1—seminal vesicle—sarcoma	0.000769	0.00267	CbGeAlD
Adenosine triphosphate—HSPA1A—Vinblastine—Vincristine—sarcoma	0.000765	0.091	CbGdCrCtD
Adenosine triphosphate—SLC25A4—tendon—sarcoma	0.000761	0.00264	CbGeAlD
Adenosine triphosphate—ACVR1—cardiac atrium—sarcoma	0.000757	0.00263	CbGeAlD
Adenosine triphosphate—HSPA1B—liver—sarcoma	0.000756	0.00263	CbGeAlD
Adenosine triphosphate—HSPA1A—liver—sarcoma	0.000756	0.00263	CbGeAlD
Adenosine triphosphate—ABL1—mammary gland—sarcoma	0.000754	0.00262	CbGeAlD
Adenosine triphosphate—ACVR1—uterus—sarcoma	0.000753	0.00262	CbGeAlD
Adenosine triphosphate—NT5C2—uterus—sarcoma	0.000753	0.00262	CbGeAlD
Adenosine triphosphate—ARAF—testis—sarcoma	0.000748	0.0026	CbGeAlD
Adenosine triphosphate—ADK—myometrium—sarcoma	0.000743	0.00258	CbGeAlD
Adenosine triphosphate—ACSS2—cardiac atrium—sarcoma	0.000742	0.00258	CbGeAlD
Adenosine triphosphate—ASNS—smooth muscle tissue—sarcoma	0.000738	0.00256	CbGeAlD
Adenosine triphosphate—AKT1—smooth muscle tissue—sarcoma	0.000738	0.00256	CbGeAlD
Adenosine triphosphate—ACSS2—uterus—sarcoma	0.000738	0.00256	CbGeAlD
Adenosine triphosphate—ACSL1—cardiac atrium—sarcoma	0.000737	0.00256	CbGeAlD
Adenosine triphosphate—ACSL1—uterus—sarcoma	0.000733	0.00255	CbGeAlD
Adenosine triphosphate—AKT1—skin of body—sarcoma	0.000729	0.00253	CbGeAlD
Adenosine triphosphate—ACVR1B—testis—sarcoma	0.000726	0.00252	CbGeAlD
Adenosine triphosphate—ADRBK1—lymphoid tissue—sarcoma	0.000718	0.00249	CbGeAlD
Adenosine triphosphate—ABCA1—lymphoid tissue—sarcoma	0.00071	0.00246	CbGeAlD
Adenosine triphosphate—ARAF—liver—sarcoma	0.000707	0.00246	CbGeAlD
Adenosine triphosphate—NT5C2—lymphoid tissue—sarcoma	0.000702	0.00244	CbGeAlD
Adenosine triphosphate—ASNA1—testis—sarcoma	0.000702	0.00244	CbGeAlD
Adenosine triphosphate—AFG3L2—testis—sarcoma	0.000693	0.00241	CbGeAlD
Adenosine triphosphate—ACVR1B—liver—sarcoma	0.000687	0.00238	CbGeAlD
Adenosine triphosphate—ADRBK2—lymph node—sarcoma	0.000685	0.00238	CbGeAlD
Adenosine triphosphate—ACSL1—lymphoid tissue—sarcoma	0.000683	0.00237	CbGeAlD
Adenosine triphosphate—NAE1—testis—sarcoma	0.000676	0.00235	CbGeAlD
Adenosine triphosphate—ACSS1—tendon—sarcoma	0.000675	0.00234	CbGeAlD
Adenosine triphosphate—ADK—seminal vesicle—sarcoma	0.000672	0.00233	CbGeAlD
Adenosine triphosphate—ASNA1—liver—sarcoma	0.000664	0.0023	CbGeAlD
Adenosine triphosphate—NT5C2—tendon—sarcoma	0.00066	0.00229	CbGeAlD
Adenosine triphosphate—ACVR1—tendon—sarcoma	0.00066	0.00229	CbGeAlD
Adenosine triphosphate—AFG3L2—liver—sarcoma	0.000655	0.00227	CbGeAlD
Adenosine triphosphate—ADRBK1—bone marrow—sarcoma	0.000653	0.00227	CbGeAlD
Adenosine triphosphate—ACSS1—bone marrow—sarcoma	0.000653	0.00227	CbGeAlD
Adenosine triphosphate—PRKAA1—lymphoid tissue—sarcoma	0.000647	0.00225	CbGeAlD
Adenosine triphosphate—ACSS2—tendon—sarcoma	0.000647	0.00224	CbGeAlD
Adenosine triphosphate—ASS1—smooth muscle tissue—sarcoma	0.000644	0.00223	CbGeAlD
Adenosine triphosphate—ALK—testis—sarcoma	0.000643	0.00223	CbGeAlD
Adenosine triphosphate—ACSL1—tendon—sarcoma	0.000642	0.00223	CbGeAlD
Adenosine triphosphate—ACVR1—bone marrow—sarcoma	0.000639	0.00222	CbGeAlD
Adenosine triphosphate—NT5C2—bone marrow—sarcoma	0.000639	0.00222	CbGeAlD
Adenosine triphosphate—NAE1—liver—sarcoma	0.000639	0.00222	CbGeAlD
Adenosine triphosphate—ADK—hematopoietic system—sarcoma	0.000638	0.00222	CbGeAlD
Adenosine triphosphate—ASNS—cardiac atrium—sarcoma	0.000637	0.00221	CbGeAlD
Adenosine triphosphate—AKT1—cardiac atrium—sarcoma	0.000637	0.00221	CbGeAlD
Adenosine triphosphate—ASS1—skin of body—sarcoma	0.000635	0.00221	CbGeAlD
Adenosine triphosphate—AKT1—uterus—sarcoma	0.000633	0.0022	CbGeAlD
Adenosine triphosphate—ASNS—uterus—sarcoma	0.000633	0.0022	CbGeAlD
Adenosine triphosphate—ABL2—tendon—sarcoma	0.00063	0.00219	CbGeAlD
Adenosine triphosphate—SLC25A4—testis—sarcoma	0.00063	0.00219	CbGeAlD
Adenosine triphosphate—ACSS2—bone marrow—sarcoma	0.000626	0.00217	CbGeAlD
Adenosine triphosphate—ABCC8—seminal vesicle—sarcoma	0.000623	0.00216	CbGeAlD
Adenosine triphosphate—ACSL1—bone marrow—sarcoma	0.000622	0.00216	CbGeAlD
Adenosine triphosphate—ABCG1—lymph node—sarcoma	0.000621	0.00216	CbGeAlD
Adenosine triphosphate—ACVRL1—lymph node—sarcoma	0.000621	0.00216	CbGeAlD
Adenosine triphosphate—TNK2—testis—sarcoma	0.000618	0.00214	CbGeAlD
Adenosine triphosphate—ADCY1—lymph node—sarcoma	0.000602	0.00209	CbGeAlD
Adenosine triphosphate—SLC25A4—liver—sarcoma	0.000595	0.00207	CbGeAlD
Adenosine triphosphate—ABCC9—lymph node—sarcoma	0.000591	0.00205	CbGeAlD
Adenosine triphosphate—AKT1—lymphoid tissue—sarcoma	0.00059	0.00205	CbGeAlD
Adenosine triphosphate—PRKAA1—bone marrow—sarcoma	0.000589	0.00204	CbGeAlD
Adenosine triphosphate—TNK2—liver—sarcoma	0.000584	0.00203	CbGeAlD
Adenosine triphosphate—HSPA1B—lymph node—sarcoma	0.00058	0.00201	CbGeAlD
Adenosine triphosphate—HSPA1A—lymph node—sarcoma	0.00058	0.00201	CbGeAlD
Adenosine triphosphate—HSPA1A—Idarubicin—Epirubicin—sarcoma	0.000579	0.0689	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Epirubicin—sarcoma	0.000579	0.0689	CbGdCrCtD
Adenosine triphosphate—ADK—smooth muscle tissue—sarcoma	0.000562	0.00195	CbGeAlD
Adenosine triphosphate—ACSS1—testis—sarcoma	0.000559	0.00194	CbGeAlD
Adenosine triphosphate—ADRBK1—testis—sarcoma	0.000559	0.00194	CbGeAlD
Adenosine triphosphate—ASS1—cardiac atrium—sarcoma	0.000555	0.00193	CbGeAlD
Adenosine triphosphate—ADK—skin of body—sarcoma	0.000555	0.00193	CbGeAlD
Adenosine triphosphate—AKT1—tendon—sarcoma	0.000555	0.00193	CbGeAlD
Adenosine triphosphate—ASNS—tendon—sarcoma	0.000555	0.00193	CbGeAlD
Adenosine triphosphate—ABCA1—testis—sarcoma	0.000552	0.00192	CbGeAlD
Adenosine triphosphate—ASS1—uterus—sarcoma	0.000552	0.00192	CbGeAlD
Adenosine triphosphate—NT5C2—testis—sarcoma	0.000547	0.0019	CbGeAlD
Adenosine triphosphate—ACVR1—testis—sarcoma	0.000547	0.0019	CbGeAlD
Adenosine triphosphate—ARAF—lymph node—sarcoma	0.000542	0.00188	CbGeAlD
Adenosine triphosphate—AKT1—bone marrow—sarcoma	0.000537	0.00187	CbGeAlD
Adenosine triphosphate—ASNS—bone marrow—sarcoma	0.000537	0.00187	CbGeAlD
Adenosine triphosphate—HSPA1A—Idarubicin—Doxorubicin—sarcoma	0.000536	0.0638	CbGdCrCtD
Adenosine triphosphate—HSPA1A—Daunorubicin—Doxorubicin—sarcoma	0.000536	0.0638	CbGdCrCtD
Adenosine triphosphate—ACSS2—testis—sarcoma	0.000535	0.00186	CbGeAlD
Adenosine triphosphate—ABL1—myometrium—sarcoma	0.000535	0.00186	CbGeAlD
Adenosine triphosphate—ACSL1—testis—sarcoma	0.000532	0.00185	CbGeAlD
Adenosine triphosphate—ACSS1—liver—sarcoma	0.000528	0.00183	CbGeAlD
Adenosine triphosphate—ACVR1B—lymph node—sarcoma	0.000526	0.00183	CbGeAlD
Adenosine triphosphate—ABCA1—liver—sarcoma	0.000522	0.00181	CbGeAlD
Adenosine triphosphate—ABL2—testis—sarcoma	0.000522	0.00181	CbGeAlD
Adenosine triphosphate—ABCC8—smooth muscle tissue—sarcoma	0.000521	0.00181	CbGeAlD
Adenosine triphosphate—ACVR1—liver—sarcoma	0.000517	0.00179	CbGeAlD
Adenosine triphosphate—NT5C2—liver—sarcoma	0.000517	0.00179	CbGeAlD
Adenosine triphosphate—ABL1—embryo—sarcoma	0.000515	0.00179	CbGeAlD
Adenosine triphosphate—ASNA1—lymph node—sarcoma	0.000509	0.00177	CbGeAlD
Adenosine triphosphate—ACSS2—liver—sarcoma	0.000506	0.00176	CbGeAlD
Adenosine triphosphate—PRKAA1—testis—sarcoma	0.000503	0.00175	CbGeAlD
Adenosine triphosphate—ACSL1—liver—sarcoma	0.000503	0.00175	CbGeAlD
Adenosine triphosphate—AFG3L2—lymph node—sarcoma	0.000502	0.00174	CbGeAlD
Adenosine triphosphate—ABL2—liver—sarcoma	0.000493	0.00171	CbGeAlD
Adenosine triphosphate—NAE1—lymph node—sarcoma	0.00049	0.0017	CbGeAlD
Adenosine triphosphate—ADK—cardiac atrium—sarcoma	0.000485	0.00168	CbGeAlD
Adenosine triphosphate—ASS1—tendon—sarcoma	0.000484	0.00168	CbGeAlD
Adenosine triphosphate—ABL1—seminal vesicle—sarcoma	0.000483	0.00168	CbGeAlD
Adenosine triphosphate—PRKAA1—liver—sarcoma	0.000476	0.00165	CbGeAlD
Adenosine triphosphate—ALK—lymph node—sarcoma	0.000466	0.00162	CbGeAlD
Adenosine triphosphate—ASNS—testis—sarcoma	0.000459	0.00159	CbGeAlD
Adenosine triphosphate—AKT1—testis—sarcoma	0.000459	0.00159	CbGeAlD
Adenosine triphosphate—ABL1—hematopoietic system—sarcoma	0.000459	0.00159	CbGeAlD
Adenosine triphosphate—SLC25A4—lymph node—sarcoma	0.000456	0.00158	CbGeAlD
Adenosine triphosphate—ADK—lymphoid tissue—sarcoma	0.000449	0.00156	CbGeAlD
Adenosine triphosphate—TNK2—lymph node—sarcoma	0.000448	0.00155	CbGeAlD
Adenosine triphosphate—ABL1—connective tissue—sarcoma	0.000442	0.00154	CbGeAlD
Adenosine triphosphate—ABL1—Daunorubicin—Epirubicin—sarcoma	0.000439	0.0522	CbGdCrCtD
Adenosine triphosphate—ABL1—Doxorubicin—Epirubicin—sarcoma	0.000439	0.0522	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Epirubicin—sarcoma	0.000439	0.0522	CbGdCrCtD
Adenosine triphosphate—AKT1—liver—sarcoma	0.000434	0.00151	CbGeAlD
Adenosine triphosphate—ASNS—liver—sarcoma	0.000434	0.00151	CbGeAlD
Adenosine triphosphate—ABCB11—testis—sarcoma	0.000428	0.00149	CbGeAlD
Adenosine triphosphate—ADK—tendon—sarcoma	0.000422	0.00147	CbGeAlD
Adenosine triphosphate—ADK—bone marrow—sarcoma	0.000409	0.00142	CbGeAlD
Adenosine triphosphate—ABL1—Daunorubicin—Doxorubicin—sarcoma	0.000406	0.0483	CbGdCrCtD
Adenosine triphosphate—ABL1—Epirubicin—Doxorubicin—sarcoma	0.000406	0.0483	CbGdCrCtD
Adenosine triphosphate—ABL1—Idarubicin—Doxorubicin—sarcoma	0.000406	0.0483	CbGdCrCtD
Adenosine triphosphate—ACSS1—lymph node—sarcoma	0.000405	0.00141	CbGeAlD
Adenosine triphosphate—ADRBK1—lymph node—sarcoma	0.000405	0.00141	CbGeAlD
Adenosine triphosphate—ABCB11—liver—sarcoma	0.000405	0.0014	CbGeAlD
Adenosine triphosphate—ABL1—smooth muscle tissue—sarcoma	0.000405	0.0014	CbGeAlD
Adenosine triphosphate—ASS1—testis—sarcoma	0.000401	0.00139	CbGeAlD
Adenosine triphosphate—ABCA1—lymph node—sarcoma	0.0004	0.00139	CbGeAlD
Adenosine triphosphate—ABL1—skin of body—sarcoma	0.000399	0.00139	CbGeAlD
Adenosine triphosphate—ACVR1—lymph node—sarcoma	0.000396	0.00138	CbGeAlD
Adenosine triphosphate—NT5C2—lymph node—sarcoma	0.000396	0.00138	CbGeAlD
Adenosine triphosphate—ACSS2—lymph node—sarcoma	0.000388	0.00135	CbGeAlD
Adenosine triphosphate—ACSL1—lymph node—sarcoma	0.000386	0.00134	CbGeAlD
Adenosine triphosphate—ASS1—liver—sarcoma	0.000379	0.00131	CbGeAlD
Adenosine triphosphate—ABL2—lymph node—sarcoma	0.000378	0.00131	CbGeAlD
Adenosine triphosphate—PRKAA1—lymph node—sarcoma	0.000365	0.00127	CbGeAlD
Adenosine triphosphate—ADK—testis—sarcoma	0.00035	0.00121	CbGeAlD
Adenosine triphosphate—ABL1—cardiac atrium—sarcoma	0.000349	0.00121	CbGeAlD
Adenosine triphosphate—ABL1—uterus—sarcoma	0.000347	0.0012	CbGeAlD
Adenosine triphosphate—AKT1—lymph node—sarcoma	0.000333	0.00116	CbGeAlD
Adenosine triphosphate—ASNS—lymph node—sarcoma	0.000333	0.00116	CbGeAlD
Adenosine triphosphate—ADK—liver—sarcoma	0.000331	0.00115	CbGeAlD
Adenosine triphosphate—ABCC8—testis—sarcoma	0.000324	0.00113	CbGeAlD
Adenosine triphosphate—ABL1—lymphoid tissue—sarcoma	0.000323	0.00112	CbGeAlD
Adenosine triphosphate—ABL1—tendon—sarcoma	0.000304	0.00106	CbGeAlD
Adenosine triphosphate—ABL1—bone marrow—sarcoma	0.000294	0.00102	CbGeAlD
Adenosine triphosphate—ASS1—lymph node—sarcoma	0.00029	0.00101	CbGeAlD
Adenosine triphosphate—ABCC2—tendon—sarcoma	0.000263	0.000913	CbGeAlD
Adenosine triphosphate—ADK—lymph node—sarcoma	0.000254	0.00088	CbGeAlD
Adenosine triphosphate—ABL1—testis—sarcoma	0.000252	0.000874	CbGeAlD
Adenosine triphosphate—ABL1—liver—sarcoma	0.000238	0.000826	CbGeAlD
Adenosine triphosphate—ABCC2—testis—sarcoma	0.000218	0.000756	CbGeAlD
Adenosine triphosphate—ABCC2—liver—sarcoma	0.000206	0.000714	CbGeAlD
Adenosine triphosphate—ABL1—lymph node—sarcoma	0.000182	0.000633	CbGeAlD
Adenosine triphosphate—ABCB1—myometrium—sarcoma	0.000166	0.000577	CbGeAlD
Adenosine triphosphate—ABCB1—embryo—sarcoma	0.00016	0.000555	CbGeAlD
Adenosine triphosphate—ABCC2—lymph node—sarcoma	0.000158	0.000548	CbGeAlD
Adenosine triphosphate—ABCB1—seminal vesicle—sarcoma	0.00015	0.000522	CbGeAlD
Adenosine triphosphate—ABCB1—hematopoietic system—sarcoma	0.000143	0.000496	CbGeAlD
Adenosine triphosphate—ABCB1—uterus—sarcoma	0.000108	0.000375	CbGeAlD
Adenosine triphosphate—ABCB1—lymphoid tissue—sarcoma	0.000101	0.000349	CbGeAlD
Adenosine triphosphate—ABCB1—bone marrow—sarcoma	9.16e-05	0.000318	CbGeAlD
Adenosine triphosphate—ABCB1—testis—sarcoma	7.83e-05	0.000272	CbGeAlD
Adenosine triphosphate—ABCB1—liver—sarcoma	7.4e-05	0.000257	CbGeAlD
Adenosine triphosphate—ABCB1—lymph node—sarcoma	5.67e-05	0.000197	CbGeAlD
Adenosine triphosphate—ADCY1—Disease—CREB1—sarcoma	2.43e-05	7.63e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—EGFR—sarcoma	2.43e-05	7.63e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—KRAS—sarcoma	2.42e-05	7.58e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—PDGFRA—sarcoma	2.41e-05	7.55e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—KRAS—sarcoma	2.39e-05	7.51e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—MDM2—sarcoma	2.36e-05	7.42e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1B—Disease—HRAS—sarcoma	2.36e-05	7.4e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—FOXO1—sarcoma	2.35e-05	7.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—GPCR downstream signaling—IL2—sarcoma	2.35e-05	7.36e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—IL2—sarcoma	2.35e-05	7.36e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PDGFRB—sarcoma	2.34e-05	7.35e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.34e-05	7.35e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—MYC—sarcoma	2.32e-05	7.29e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—CTNNB1—sarcoma	2.31e-05	7.25e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—PDGFRA—sarcoma	2.31e-05	7.24e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—KRAS—sarcoma	2.3e-05	7.2e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—FOXO1—sarcoma	2.29e-05	7.2e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PDGFRB—sarcoma	2.29e-05	7.19e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by NGF—HRAS—sarcoma	2.27e-05	7.14e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—EGFR—sarcoma	2.27e-05	7.14e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—MDM2—sarcoma	2.27e-05	7.13e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—MDM2—sarcoma	2.27e-05	7.12e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—PDGFRA—sarcoma	2.25e-05	7.08e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—MDM2—sarcoma	2.24e-05	7.03e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—IL2—sarcoma	2.22e-05	6.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—IL2—sarcoma	2.22e-05	6.97e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KDR—sarcoma	2.2e-05	6.9e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—CTNNB1—sarcoma	2.19e-05	6.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—MDM2—sarcoma	2.18e-05	6.84e-05	CbGpPWpGaD
Adenosine triphosphate—HSPA1A—Disease—HRAS—sarcoma	2.18e-05	6.83e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—FOXO1—sarcoma	2.18e-05	6.83e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PDGFRB—sarcoma	2.17e-05	6.81e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—KRAS—sarcoma	2.15e-05	6.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Innate Immune System—HRAS—sarcoma	2.14e-05	6.72e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—PDGFRA—sarcoma	2.14e-05	6.71e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—IL2—sarcoma	2.13e-05	6.69e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—FLT1—sarcoma	2.13e-05	6.68e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—FOXO1—sarcoma	2.12e-05	6.65e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PDGFRB—sarcoma	2.11e-05	6.64e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—MDM2—sarcoma	2.1e-05	6.58e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PLCG1—sarcoma	2.09e-05	6.56e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—SRC—sarcoma	2.09e-05	6.55e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—PDGFRA—sarcoma	2.08e-05	6.53e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—JUN—sarcoma	2.05e-05	6.45e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Innate Immune System—HRAS—sarcoma	2.05e-05	6.44e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—SRC—sarcoma	2.05e-05	6.43e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—CTNNB1—sarcoma	2.04e-05	6.4e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.04e-05	6.4e-05	CbGpPWpGaD
Adenosine triphosphate—SLC25A4—Disease—HRAS—sarcoma	2.04e-05	6.39e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.03e-05	6.39e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—VEGFA—sarcoma	2.03e-05	6.38e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—IL2—sarcoma	2.03e-05	6.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KDR—sarcoma	2.03e-05	6.36e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KIT—sarcoma	2.03e-05	6.35e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.02e-05	6.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MDM2—sarcoma	2.01e-05	6.31e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CXCR4—sarcoma	2.01e-05	6.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—NRAS—sarcoma	2.01e-05	6.3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—VEGFA—sarcoma	1.99e-05	6.26e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—ATF1—sarcoma	1.99e-05	6.23e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—SRC—sarcoma	1.98e-05	6.21e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—JUN—sarcoma	1.98e-05	6.2e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—NRAS—sarcoma	1.97e-05	6.18e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—CTNNB1—sarcoma	1.96e-05	6.15e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Axon guidance—HRAS—sarcoma	1.95e-05	6.12e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—JUN—sarcoma	1.95e-05	6.11e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—IL2—sarcoma	1.95e-05	6.11e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KDR—sarcoma	1.94e-05	6.09e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—SRC—sarcoma	1.94e-05	6.09e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—CTNNB1—sarcoma	1.93e-05	6.07e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CREB1—sarcoma	1.93e-05	6.05e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—VEGFA—sarcoma	1.93e-05	6.05e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—TP53—sarcoma	1.91e-05	5.99e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—NRAS—sarcoma	1.9e-05	5.97e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—JUN—sarcoma	1.89e-05	5.94e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—VEGFA—sarcoma	1.89e-05	5.93e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—CTNNB1—sarcoma	1.88e-05	5.9e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—NRAS—sarcoma	1.87e-05	5.86e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KIT—sarcoma	1.87e-05	5.86e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—NRAS—sarcoma	1.87e-05	5.86e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—SRC—sarcoma	1.84e-05	5.78e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—EGFR—sarcoma	1.83e-05	5.74e-05	CbGpPWpGaD
Adenosine triphosphate—ACVR1B—Signaling Pathways—HRAS—sarcoma	1.83e-05	5.73e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.83e-05	5.73e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—CREB1—sarcoma	1.82e-05	5.72e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—CTNNB1—sarcoma	1.81e-05	5.68e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KIT—sarcoma	1.79e-05	5.61e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—NRAS—sarcoma	1.79e-05	5.61e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.78e-05	5.58e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CREB1—sarcoma	1.78e-05	5.57e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—NRAS—sarcoma	1.77e-05	5.56e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—SRC—sarcoma	1.77e-05	5.56e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—SRC—sarcoma	1.77e-05	5.55e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KIT—sarcoma	1.75e-05	5.49e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—SRC—sarcoma	1.75e-05	5.48e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—CTNNB1—sarcoma	1.74e-05	5.45e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—EGFR—sarcoma	1.73e-05	5.44e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—KRAS—sarcoma	1.73e-05	5.42e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—NRAS—sarcoma	1.7e-05	5.35e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—NRAS—sarcoma	1.7e-05	5.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CREB1—sarcoma	1.7e-05	5.34e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—EGFR—sarcoma	1.7e-05	5.33e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—SRC—sarcoma	1.7e-05	5.33e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—KRAS—sarcoma	1.7e-05	5.32e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—NRAS—sarcoma	1.68e-05	5.28e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CREB1—sarcoma	1.66e-05	5.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KIT—sarcoma	1.66e-05	5.2e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—KRAS—sarcoma	1.64e-05	5.14e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—SRC—sarcoma	1.64e-05	5.13e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.64e-05	5.13e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—NRAS—sarcoma	1.63e-05	5.13e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—EGFR—sarcoma	1.63e-05	5.11e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—EGFR—sarcoma	1.62e-05	5.07e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—KIT—sarcoma	1.61e-05	5.07e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—KRAS—sarcoma	1.61e-05	5.04e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—KRAS—sarcoma	1.61e-05	5.04e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.6e-05	5.02e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MDM2—sarcoma	1.59e-05	5e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CREB1—sarcoma	1.58e-05	4.95e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—NRAS—sarcoma	1.57e-05	4.94e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—SRC—sarcoma	1.57e-05	4.92e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IGF1R—sarcoma	1.56e-05	4.89e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—EGFR—sarcoma	1.55e-05	4.87e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—EGFR—sarcoma	1.55e-05	4.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—KRAS—sarcoma	1.54e-05	4.83e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CREB1—sarcoma	1.54e-05	4.82e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—EGFR—sarcoma	1.53e-05	4.81e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—KRAS—sarcoma	1.53e-05	4.79e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.51e-05	4.74e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—NRAS—sarcoma	1.51e-05	4.74e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—TP53—sarcoma	1.51e-05	4.73e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—EGFR—sarcoma	1.49e-05	4.67e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—FOXO1—sarcoma	1.48e-05	4.66e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—GPCR downstream signaling—IL2—sarcoma	1.48e-05	4.65e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PDGFRB—sarcoma	1.48e-05	4.65e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MDM2—sarcoma	1.47e-05	4.61e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Developmental Biology—HRAS—sarcoma	1.47e-05	4.61e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—KRAS—sarcoma	1.47e-05	4.6e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—MYC—sarcoma	1.47e-05	4.6e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—KRAS—sarcoma	1.47e-05	4.6e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—PDGFRA—sarcoma	1.46e-05	4.57e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—KRAS—sarcoma	1.45e-05	4.54e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Hemostasis—HRAS—sarcoma	1.44e-05	4.52e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—EGFR—sarcoma	1.43e-05	4.5e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—TP53—sarcoma	1.43e-05	4.48e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—IL2—sarcoma	1.43e-05	4.47e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MDM2—sarcoma	1.41e-05	4.42e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—KRAS—sarcoma	1.41e-05	4.41e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—MYC—sarcoma	1.41e-05	4.41e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Developmental Biology—HRAS—sarcoma	1.39e-05	4.37e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CCND1—sarcoma	1.39e-05	4.36e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—JUN—sarcoma	1.39e-05	4.35e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—MDM2—sarcoma	1.38e-05	4.32e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—CTNNB1—sarcoma	1.38e-05	4.32e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—EGFR—sarcoma	1.37e-05	4.31e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Hemostasis—HRAS—sarcoma	1.37e-05	4.29e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling by GPCR—HRAS—sarcoma	1.36e-05	4.28e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—KRAS—sarcoma	1.35e-05	4.25e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—IL2—sarcoma	1.35e-05	4.23e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.34e-05	4.21e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—IL2—sarcoma	1.31e-05	4.12e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling by GPCR—HRAS—sarcoma	1.31e-05	4.11e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—MDM2—sarcoma	1.31e-05	4.1e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—KRAS—sarcoma	1.3e-05	4.08e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Innate Immune System—HRAS—sarcoma	1.3e-05	4.07e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CCND1—sarcoma	1.28e-05	4.02e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—JUN—sarcoma	1.28e-05	4.01e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MDM2—sarcoma	1.27e-05	3.99e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—CTNNB1—sarcoma	1.27e-05	3.98e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—IL2—sarcoma	1.26e-05	3.95e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Immune System—HRAS—sarcoma	1.25e-05	3.91e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Adaptive Immune System—HRAS—sarcoma	1.25e-05	3.91e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—SRC—sarcoma	1.24e-05	3.9e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—IL2—sarcoma	1.23e-05	3.86e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Innate Immune System—HRAS—sarcoma	1.23e-05	3.86e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CCND1—sarcoma	1.23e-05	3.85e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KDR—sarcoma	1.23e-05	3.85e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—JUN—sarcoma	1.22e-05	3.84e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—CTNNB1—sarcoma	1.22e-05	3.81e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—VEGFA—sarcoma	1.21e-05	3.8e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—ENO2—sarcoma	1.2e-05	3.78e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—HBA1—sarcoma	1.2e-05	3.76e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—JUN—sarcoma	1.2e-05	3.76e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—NRAS—sarcoma	1.2e-05	3.75e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Immune System—HRAS—sarcoma	1.2e-05	3.75e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—CTNNB1—sarcoma	1.19e-05	3.73e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—IL2—sarcoma	1.17e-05	3.66e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Disease—HRAS—sarcoma	1.15e-05	3.61e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—SRC—sarcoma	1.15e-05	3.6e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—JUN—sarcoma	1.13e-05	3.56e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KIT—sarcoma	1.13e-05	3.55e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—NRAS—sarcoma	1.13e-05	3.55e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—CTNNB1—sarcoma	1.13e-05	3.53e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—VEGFA—sarcoma	1.12e-05	3.5e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—MYC—sarcoma	1.11e-05	3.5e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Disease—HRAS—sarcoma	1.1e-05	3.46e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—NRAS—sarcoma	1.1e-05	3.46e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—SRC—sarcoma	1.1e-05	3.45e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—CTNNB1—sarcoma	1.1e-05	3.44e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—EGFR—sarcoma	1.09e-05	3.42e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CREB1—sarcoma	1.08e-05	3.38e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—SRC—sarcoma	1.07e-05	3.37e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—VEGFA—sarcoma	1.07e-05	3.36e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—NRAS—sarcoma	1.06e-05	3.32e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—NRAS—sarcoma	1.03e-05	3.24e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—EGFR—sarcoma	1.03e-05	3.23e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—KRAS—sarcoma	1.03e-05	3.23e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—MYC—sarcoma	1.03e-05	3.22e-05	CbGpPWpGaD
Adenosine triphosphate—ABCB1—Metabolism—PLCG1—sarcoma	1.02e-05	3.21e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—SRC—sarcoma	1.02e-05	3.19e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—EGFR—sarcoma	1e-05	3.15e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—SRC—sarcoma	9.91e-06	3.11e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—MYC—sarcoma	9.84e-06	3.09e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—NRAS—sarcoma	9.79e-06	3.07e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—KRAS—sarcoma	9.73e-06	3.05e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—EGFR—sarcoma	9.63e-06	3.02e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Gene Expression—MYC—sarcoma	9.57e-06	3e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—NRAS—sarcoma	9.54e-06	2.99e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—KRAS—sarcoma	9.49e-06	2.98e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—EGFR—sarcoma	9.41e-06	2.95e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—TP53—sarcoma	9.15e-06	2.87e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—KRAS—sarcoma	9.09e-06	2.85e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—EGFR—sarcoma	8.92e-06	2.8e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MDM2—sarcoma	8.9e-06	2.79e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—KRAS—sarcoma	8.89e-06	2.79e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—MYC—sarcoma	8.88e-06	2.79e-05	CbGpPWpGaD
Adenosine triphosphate—PRKAA1—Signaling Pathways—HRAS—sarcoma	8.75e-06	2.75e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—EGFR—sarcoma	8.69e-06	2.73e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—TP53—sarcoma	8.43e-06	2.65e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—KRAS—sarcoma	8.43e-06	2.64e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling by GPCR—HRAS—sarcoma	8.27e-06	2.6e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—KRAS—sarcoma	8.21e-06	2.58e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—TP53—sarcoma	8.08e-06	2.54e-05	CbGpPWpGaD
Adenosine triphosphate—ADRBK1—Signaling Pathways—HRAS—sarcoma	8.06e-06	2.53e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—IL2—sarcoma	7.95e-06	2.5e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CCND1—sarcoma	7.75e-06	2.43e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—JUN—sarcoma	7.74e-06	2.43e-05	CbGpPWpGaD
Adenosine triphosphate—ADCY1—Signaling Pathways—HRAS—sarcoma	7.73e-06	2.43e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—CTNNB1—sarcoma	7.68e-06	2.41e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Immune System—HRAS—sarcoma	7.56e-06	2.37e-05	CbGpPWpGaD
Adenosine triphosphate—ABL1—Immune System—HRAS—sarcoma	7.16e-06	2.25e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Disease—HRAS—sarcoma	6.98e-06	2.19e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—SRC—sarcoma	6.94e-06	2.18e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—VEGFA—sarcoma	6.76e-06	2.12e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—NRAS—sarcoma	6.68e-06	2.1e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—MYC—sarcoma	6.22e-06	1.95e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—EGFR—sarcoma	6.08e-06	1.91e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—KRAS—sarcoma	5.75e-06	1.8e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—TP53—sarcoma	5.11e-06	1.6e-05	CbGpPWpGaD
Adenosine triphosphate—AKT1—Signaling Pathways—HRAS—sarcoma	4.89e-06	1.53e-05	CbGpPWpGaD
